Italian biotech developing a blood-based test for early Alzheimer's detection.
| Date | Round | Amount |
|---|---|---|
| Apr 2022 | Funding round Brescia biotech Diadem raised a 10M euro first tranche led by CDP Venture Capital and Panakes Partners for its Alzheimer's blood test. | $10M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.